Dr. Hirsch-Moverman is an epidemiologist with over 20 years of experience in epidemiologic and implementation research in TB and HIV. Her deep immersion in TB and HIV prevention and treatment research began in NYC, investigating and comparing different approaches to increase adherence to medications among underserved populations. Ultimately her focus broadened to Africa, where an explosion of TB cases has overlapped with the HIV epidemic.

Dr. Hirsch-Moverman's work has spanned biomedical domains including epidemiology and clinical trials, and behavioral domains including psychosocial issues such as adherence. She is currently focused on designing, conducting, and analyzing the effectiveness and acceptability of interventions to improve patient-centered care in TB and HIV programs in resource-limited settings, where TB/HIV infection rates are high. She supports and leads a number of implementation science research studies that focus on the development of evidence-based novel approaches for TB prevention among children in resource-limited settings.

Another aspect of her work focuses on the prevention of HIV in vulnerable populations in the US, namely men who have sex with men (MSM) and transgender women (TGW). She is based at the Harlem Prevention Center Clinical Research Site (CRS), which is funded by NIAID to conduct HIV prevention and COVID-19 prevention research studies. In addition, the center conducts investigator-initiated research studies examining interventions that increase access to HIV testing and pre-exposure prophylaxis among MSM and TGW.